Nankai ChemicalNANKAI CHEMICAL COMPANY, LIMITED4040東証スタンダード化学FY ending Mar 2026, consolidated, J-GAAP

Nankai Chemical revenue and profit

Out of every ¥100 of sales, about ¥8 is left as operating profit. Revenue changed +0.8% from the prior year, operating profit +30.2%.

Five-year trend

Revenue¥21.1B
FY ending Mar 2022: ¥17.4B¥17.4BFY ending Mar 2023: ¥19.6B¥19.6BFY ending Mar 2024: ¥20B¥20BFY ending Mar 2025: ¥20.9B¥20.9BFY ending Mar 2026: ¥21.1B¥21.1BFY22FY23FY24FY25FY26
Operating income¥1.7B
FY ending Mar 2022: ¥739M¥739MFY ending Mar 2023: ¥796M¥796MFY ending Mar 2024: ¥1.56B¥1.56BFY ending Mar 2025: ¥1.31B¥1.31BFY ending Mar 2026: ¥1.7B¥1.7BFY22FY23FY24FY25FY26
Operating margin8.1%
FY ending Mar 2022: 4.2%4.2%FY ending Mar 2023: 4.1%4.1%FY ending Mar 2024: 7.8%7.8%FY ending Mar 2025: 6.2%6.2%FY ending Mar 2026: 8.1%8.1%FY22FY23FY24FY25FY26

What drives ROE

Net margin × asset turnover = ROA; ROA × financial leverage = ROE

Net margin13.2%
Asset turnover1.00×
ROA13.2%
ROA13.2%
Financial leverage2.23×
ROE29.5%

Denominators: average assets and average equity. Derived from reported values; ROE is shown only for positive profit and equity.

Net margin13.2%
2022: 2.6%2.6%2023: 2.6%2.6%2024: 5.8%5.8%2025: 4.9%4.9%2026: 13.2%13.2%2223242526
Asset turnover1.00×
2022: 1.03×1.03×2023: 1.11×1.11×2024: 1.04×1.04×2025: 0.98×0.98×2026: 1.00×1.00×2223242526
ROA13.2%
2022: 2.7%2.7%2023: 2.9%2.9%2024: 6.0%6.0%2025: 4.8%4.8%2026: 13.2%13.2%2223242526
Financial leverage2.23×
2022: 3.83×3.83×2023: 3.78×3.78×2024: 3.19×3.19×2025: 2.79×2.79×2026: 2.23×2.23×2223242526
ROE29.5%
2022: 10.4%10.4%2023: 10.8%10.8%2024: 19.2%19.2%2025: 13.3%13.3%2026: 29.5%29.5%2223242526
PeriodNet marginAsset turnoverROAFinancial leverageROE
20222.6%1.03×2.7%3.83×10.4%
20232.6%1.11×2.9%3.78×10.8%
20245.8%1.04×6.0%3.19×19.2%
20254.9%0.98×4.8%2.79×13.3%
202613.2%1.00×13.2%2.23×29.5%

Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.

Asset intensity and goodwill

Annual trends in tangible-asset ratios and goodwill balance.

PPE ÷ revenue36.9%
2022: 37.9%37.9%2023: 37.4%37.4%2024: 44.9%44.9%2025: 52.4%52.4%2026: 36.9%36.9%2223242526
PPE ÷ total assets40.0%
2022: 38.9%38.9%2023: 40.0%40.0%2024: 44.3%44.3%2025: 48.8%48.8%2026: 40.0%40.0%2223242526

Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition

Investment and working-capital efficiency

Track R&D investment and how long operating capital remains tied up before sales turn into cash.

R&D spending¥276M
2023: ¥195M¥195M2024: ¥218M¥218M2025: ¥257M¥257M2026: ¥276M¥276M2223242526
R&D / revenue1.3%
2023: 1.0%1.0%2024: 1.1%1.1%2025: 1.2%1.2%2026: 1.3%1.3%2223242526

R&D is shown only for years with machine-readable disclosure. Days are estimates using year-end receivables, inventory and payables divided by annual revenue or cost of sales; financial companies are excluded.

Income statement (JPY millions)

ItemFY ending Mar 2022FY ending Mar 2023FY ending Mar 2024FY ending Mar 2025FY ending Mar 2026
Revenue17,43419,60119,98720,90021,063
Cost of revenue13,30615,09614,48215,38815,083
Gross profit4,1274,5045,5045,5125,980
SG&A3,3883,7083,9404,2064,280
Operating income7397961,5641,3061,700
Pretax income4636631,6621,3474,086
Income tax-91534842961,283
Net income attributable to owners4625041,1581,0152,776
Operating margin4.2%4.1%7.8%6.2%8.1%

Balance sheet (reported items)

Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.

Assets

Cash 10%
Property, plant and equipment 40%
3%
3%
Other assets 44%

Funding

Other liabilities 43%
Equity 57%

Each bar totals 100% of assets; other is the residual.

ItemFY ending Mar 2022FY ending Mar 2023FY ending Mar 2024FY ending Mar 2025FY ending Mar 2026
Cash and equivalents¥1.28B¥1.3B¥1.71B¥1.7B¥2.04B
Total assets¥17B¥18.3B¥20.3B¥22.5B¥19.5B
Net assets¥4.68B¥5.19B¥7.5B¥8.5B¥11.2B
Share capital¥454M¥454M¥454M¥454M¥454M
Property, plant and equipment¥6.61B¥7.34B¥8.98B¥11B¥7.78B
Intangible assets excluding goodwill¥195M¥582M¥625M¥573M¥519M
Investment securities¥430M¥474M¥475M¥427M¥520M
Current assets¥8.63B¥8.85B¥9.1B¥9.51B¥9.81B
Current liabilities¥8.34B¥7.95B¥7.99B¥9.84B¥4.97B
Short-term borrowings¥3B¥1.74B¥1.36B¥850M—
Long-term borrowings¥3.49B¥2.47B¥1.72B¥2.62B¥1.85B
Bonds—¥900M¥800M¥700M¥600M
Interest-bearing debt—¥5.11Bderived¥3.88Bderived¥4.17Bderived—
Total liabilities¥12.3B¥13.2B¥12.8B¥14B¥8.28B
Non-controlling interests¥51M¥58M¥77M¥104M¥121M
Equity attributable to owners of parent¥4.43B¥4.92B¥7.18B¥8.12B¥10.7B
Retained earnings¥6.17B¥6.66B¥7.71B¥8.6B¥11.2B
Treasury stock-¥2.42B-¥2.42B-¥1.16B-¥1.11B-¥1.19B

Sources

Show source documents (4)
  • EDINET (FSA Japan)

    有価証券報告書-第75期(2025/04/01-2026/03/31)

    ID S100YI8M2026-06-24Open
  • EDINET (FSA Japan)

    有価証券報告書-第74期(2024/04/01-2025/03/31)

    ID S100W2II2025-06-24Open
  • EDINET (FSA Japan)

    有価証券報告書-第73期(2023/04/01-2024/03/31)

    ID S100TQH62024-06-26Open
  • EDINET (FSA Japan)

    有価証券報告書-第72期(2022/04/01-2023/03/31)

    ID S100R4ZF2023-06-28Open

Extracted from XBRL: 53 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.